Successful completion of USFDA inspection at Alembic Pharmaceuticals Ltd' Oral Solid Formulation Facility (F-I) at Panelav

Alembic Pharmaceuticals Ltd has successfully completed the United States Food and Drug Administration (USFDA) inspection for its Oral Solid Formulation Facility (F-I) located at Panelav. This was a scheduled GMP inspection and was successfully completed without any Form 483 observation. The inspection was conducted from 17th July, 2024 to 26th July, 2024.

Shares of Alembic Pharmaceuticals Limited was last trading in BSE at Rs. 1217.60 as compared to the previous close of Rs. 1200.90. The total number of shares traded during the day was 18538 in over 1463 trades.

The stock hit an intraday high of Rs. 1225.20 and intraday low of 1186.30. The net turnover during the day was Rs. 22531439.00.

Source : Equity Bulls

Keywords

AlembicPharmaceuticals INE901L01018 USFDA Inspection SuccessfulCompletion